Ligand Pharmaceuticals Inc (LGND)
EBITDA Growth
247.01%
Quarterly · Period ending:
LGND EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported247.01%period ending
Latest reported247.01%period ending
LGND Quarterly EBITDA YoY % (34.62% → 247.01%)
Year-over-year change
High-resolution chart · PNG
LGND ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 38.9529% | |
| 6.4788% | |
| -2.349% | |
| 5.4282% | |
| 28.7313% | |
| 25.7188% | |
| 31.0185% | |
| 26.9205% | |
| 6.9444% | |
| 11.1111% | |
| -2,800% | |
| -93.5897% | |
| -102.8169% | |
| -58.8235% | |
| 109.8765% | |
| -225% | |
| 7.7922% | |
| -36% | |
| -30.6452% | |
| 64.7059% | |
| -242.5926% | |
| -47.0588% | |
| -82.3529% | |
| -54.5455% | |
| 200% | |
| 34.6154% |